Singapore, Sept. 16 -- OmniPathology, a US-based advanced molecular diagnostics laboratory, has announced a new international collaboration withDeltaMedical Laboratories, a leading clinical laboratory provider in Saudi Arabia.

Under this agreement, Delta Labs will market and offerOmniPathology'sproprietaryand patent-pendingswabtestfororopharyngealhumanpapillomavirus(HPV)across Saudi Arabia and the broader Middle East region. Testing will be performed exclusively at OmniPathology's world-class laboratory in Pasadena, California.

This collaboration marks OmniPathology's first international partnership and represents a significant step toward expanding global access to its innovative molecular diagnostic testing.

Oropharyngeal HPV is incr...